FES BPET-DBT for Newly Diagnosed Breast Cancer
FES BPET-DBT in Newly Diagnosed Breast Cancer
Recruiting
Early Phase 1
Interventional Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 20 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Other
Who this trial is looking for
This trial is looking for women with newly diagnosed estrogen-receptor positive breast cancer. Participants will have imaging tests done to gather information about their cancer using a special device after receiving a small dose of a radioactive substance.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I have been diagnosed with estrogen-receptor positive breast cancer.
- I have at least one breast lesion that is 1 cm or larger on a standard imaging test.
- I understand that this study is research and I agree to participate.
You may not be able to join if
- I am pregnant or breastfeeding.
- I cannot tolerate imaging procedures according to my doctor.
- I am currently taking tamoxifen or raloxifene.
- I have a medical condition that may affect my safety or participation.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Patients with newly diagnosed primary estrogen-receptor (ER) positive breast cancer, with at least one breast lesion that is 1.0 cm in diameter or greater, may be eligible for this study. Patients may participate in this study if they are at least 18 years of age. Up to 20 evaluable subjects will participate in a single imaging cohort. Study subjects will undergo imaging of the breast with a novel…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Participants will be ≥ 18 years of age.
2. Known ER positive (by immunohistochemistry) breast cancer.
3. At least one lesion ≥ 1.0 cm that is seen on standard imaging (e.g. mammogram, ultrasound, MRI, CT, FDG-PET/CT). Only one type of imaging is required to show a lesion.
4. …
Contacts